At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5 enrolled
Drug / intervention
pancreatic enzyme supplementdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients
In Brief
A clinical study evaluating pancreatic enzyme supplement for Obesity. Completed, enrolled 5 participants across 1 site.
Detailed Summary
Hypothesis: Bypass of the upper GI tract with bariatric surgery results in suppression of pancreatic function resulting in maldigestion and further malabsorption. In this study we will measure pancreatic secretion in previously obese gastric bypass patients with excessive weight loss. If malabsorption is associated with diminished pancreatic secretion, we will test over a 3 month period whether supplementation with enzyme supplements prevent further weight loss.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesUnited States
CollaboratorsSolvay Pharmaceuticals
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2007
First PostedAug 2007
Primary CompletionJul 2015
Study CompletionAug 2015
TodayJul 2026
First PostedAug 2, 2007
Enrollment StartAug 1, 2007
Primary CompletionJul 1, 2015
Study CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7.9 yearsPosted 18.9 years ago
Interventions
pancreatic enzyme supplementdrug
4 caps with meals, 2 with snacks